Celltrion USA announces submission of the Biologics License Application (BLA) of novel subcutaneous formulation of CT-P13 to U.S. Food and Drug Administration
CHICAGO--(BUSINESS WIRE)--Dec 22, 2022--
Source: wsiltv.com
Stay updated with breaking news from Iris Shaffer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CHICAGO--(BUSINESS WIRE)--Dec 22, 2022--